STOCK TITAN

BeyondSpring (BYSI) Form 4 Filings

BYSI NASDAQ

Here are the Form 4 insider transactions from BeyondSpring Inc. (BYSI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow BYSI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BYSI filings page.

Rhea-AI Summary

BeyondSpring Inc. director Majeti Jiangwen received a grant of stock options to buy 100,000 ordinary shares. The options carry an exercise price of $1.75 per share and expire on July 1, 2036.

According to the grant terms, the options vest in four equal 25% installments on the first, second, third and fourth anniversaries of July 1, 2026, as long as the director continues to serve the company. This is a compensation-related award rather than an open-market share purchase or sale.

Rhea-AI Summary

BeyondSpring Inc. granted its Chief Executive Officer, Qiu Min, stock options as part of compensation. The award covers 100,000 stock options to purchase ordinary shares at an exercise price of $1.75 per share, expiring on July 1, 2036.

The options were granted for no cash cost to the CEO and will vest in four equal 25% installments on the first, second, third, and fourth anniversaries of July 1, 2026, contingent on continued service with the company. Following this grant, the filing shows 100,000 derivative securities held from this award.

Rhea-AI Summary

BeyondSpring Inc. director and CEO Lan Huang reported an indirect transfer of 260,582 Ordinary Shares as a bona fide gift by the Lan Huang 2022 Grantor Retained Annuity Trust, leaving that trust with no shares. Other indirect holdings remain, including 253,465 shares held by the 2026 SUNSHINE GRAT and 223,291 shares held by the 2024 SPIRIT GRAT for the benefit of Dr. Huang’s children.

Rhea-AI Summary

BeyondSpring Inc. director Matthew Kirkby received a grant of stock options covering 23,902 ordinary shares. The options have an exercise price of $1.64 per share and expire on April 1, 2036. All options vest on April 1, 2027, contingent on his continuous service with the company.

Rhea-AI Summary

BeyondSpring Inc. director Patrick Fabbio received a grant of stock options covering 22,165 ordinary shares. The options have an exercise price of $1.64 per share and were issued under the company’s 2017 Omnibus Incentive Plan as part of his compensation.

All 22,165 options vest on April 1, 2027, provided he continues serving the company through that date, and they expire on April 1, 2036. This is a compensation-related award, not an open-market purchase or sale of BeyondSpring shares.

Rhea-AI Summary

BeyondSpring Inc. director Brendan Delaney received a grant of stock options for 20,427 ordinary shares on April 1, 2026 as equity compensation. The options have an exercise price of $1.64 per share and expire on April 1, 2036. All options vest on April 1, 2027, subject to his continuous service with the company through that date.

Rhea-AI Summary

BeyondSpring Inc. director Majeti Jiangwen received a grant of stock options to purchase 21,730 Ordinary Shares of the company. These options have an exercise price of $1.64 per share and expire on April 1, 2036.

All of the options will vest on April 1, 2027, provided the director continues to serve the company through that date. Following this grant, the Form 4 shows holdings of 21,730 stock options directly owned.

Rhea-AI Summary

BeyondSpring Inc. reported that Chief Scientific Officer Lu Yingjuan June received a grant of stock options for 17,840 ordinary shares. The options have an exercise price of $1.64 per share and expire on April 1, 2036.

According to the grant terms, 4,460 options will vest on each of April 1, 2027, April 1, 2028, April 1, 2029 and April 1, 2030, as long as she continues serving the company through those dates. All options were reported as directly owned following this award.

Rhea-AI Summary

BeyondSpring Inc. director and Chief Executive Officer Huang Lan received a grant of stock options to acquire 11,514 Ordinary Shares. The options have an exercise price of $1.804 per share and were awarded at no cost to the reporting person.

According to the grant terms, 2,878 options will vest on each of April 1, 2027, April 1, 2028 and April 1, 2029, and 2,880 options will vest on April 1, 2030, subject to continuous service with the company. The options expire on April 1, 2031. This is a compensation-related award rather than an open-market purchase or sale.

Rhea-AI Summary

Xu Sihai reported acquisition or exercise transactions in this Form 4 filing.

BeyondSpring Inc. director Xu Sihai received a grant of stock options covering 18,689 ordinary shares. The options have a strike price of $1.64 per share and expire on April 1, 2036.

According to the grant terms, all of these stock options vest on April 1, 2027, provided Xu continues to serve with the company through that date. This award increases his directly held derivative position to 18,689 options and reflects compensation rather than an open-market purchase or sale.